MASON GENERAL HOSPITAL
1. Target Overview & Investment Thesis
MASON GENERAL HOSPITAL is a 25-bed suburban community hospital in MASON, WA with $127.1M in net patient revenue and a -5.3% operating margin. The hospital serves a payer mix of 38.2% Medicare, 26.8% Medicaid, and 35.0% commercial.
Thesis: Turnaround. Our ML models identify $9.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.3% to 2.0% (+736bps).
| Net Revenue HCRIS | $127.1M |
| Current EBITDA COMPUTED | $-6.8M |
| Operating Margin COMPUTED | -5.3% |
| Occupancy HCRIS | 62.4% |
| Revenue / Bed COMPUTED | $5.1M |
| Net-to-Gross HCRIS | 41.6% |
| Distress Probability ML | 46.7% |
2. Market Context & Competitive Position
WA has 104 Medicare-certified hospitals with a median operating margin of -10.3%. The target's margin of -5.3% places it above the state median. Among 42 size-comparable peers (12-50 beds), the median margin is -9.5%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (12-50), prioritizing same-state peers. 42 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MASON GENERAL HOSPITAL (Target) | WA | 25 | $127.1M | -5.3% |
| FRED HUTCHINSON CANCER CENTER | WA | 20 | $1.17B | -50.0% |
| JEFFERSON GENERAL HOSPITAL | WA | 25 | $148.0M | -3.0% |
| SAMARITAN HOSPITAL | WA | 48 | $137.4M | -4.1% |
| KITTITAS VALLEY COMMUNITY HOSP | WA | 25 | $121.0M | 2.3% |
| TRI-STATE MEMORIAL HOSPITAL | WA | 25 | $107.0M | 0.8% |
| ISLAND HOSPITAL | WA | 43 | $106.1M | -15.0% |
| ASTRIA SUNNYSIDE HOSPITAL | WA | 25 | $102.5M | 1.7% |
| WHIDBEY GENERAL HOSPITAL | WA | 25 | $98.0M | -23.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.7M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $81K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-6.8M |
| + RCM Uplift | +$9.4M |
| Pro Forma EBITDA | $2.6M |
| Current Margin | -5.3% |
| Pro Forma Margin | 2.0% |
| WC Released (1x) | $4.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-10.4M | $48.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-10.4M | $50.4M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-9.4M | $77.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-9.4M | $82.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-11.5M | $5.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-11.5M | $2.3M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (26.8%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 42 hospitals with 12-50 beds
- Same-state prioritization (n=43)
- Comp margins: P25=-15.9% / P50=-9.5% / P75=-4.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.